Posted 2 years ago in Biotech/Pharmaceutical
Veracyte is pioneering molecular cytology; we are dedicated to helping people avoid unnecessary invasive procedures just to get a diagnosis and to reducing healthcare costs at the same time. We use rigorous science to unlock genomic answers from tiny numbers of cells obtained through minimally invasive methods before surgery is needed. We launched our first product the Afirma® Thyroid FNA Analysis, with a genomic test at its core in record time and have already helped save thousands of patients from unnecessary surgery due to ambiguous thyroid nodule biopsy results. Our genomic test is offered by hundreds of physicians around the country, is covered by Medicare and private payers, and is clinically validated, including in a multicenter study published in the New England Journal of Medicine. We recently announced a new genomic test in the lung cancer space, and are also developing a second product in pulmonology, targeting interstitial lung diseases. The Wall Street Journal named us to its list of top-50 venture capital-funded companies in 2011, BayBio honored us with its Fast Start award in 2012, and In Vivo: The Business and Medicine Report featured us recently as a model for how to build a molecular cytology company. In 2014 our employees voted us a Bay Area News Group Top Workplace.
Veracyte affords equal employment opportunities to all qualified persons, regardless of race, color, religion, national origin, age, sex, disability, sexual orientation, gender expression, veteran or marital status. Veracyte participates in E-Verify in the United States.
Browse applications support specialist jobs in Austin, Texas:
C3 Consulting - Austin, TX
Posted 20 days ago on ZipRecruiter - ZipApply
Volt Information Sciences - Austin, TX
Posted 5 days ago on the web
Texas Department of Public Safety - Austin, TX
Posted 5 days ago on Beyond